Search Results

There are 83273 results for: content related to: Evolving concepts in chronic constipation in Europe and elsewhere: not worlds apart

  1. Current and Emerging Treatments for Irritable Bowel Syndrome with Constipation and Chronic Idiopathic Constipation: Focus on Prosecretory Agents

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 35, Issue 6, June 2015, Pages: 613–630, Rachel H. Thomas and David R. Luthin

    Version of Record online : 27 MAY 2015, DOI: 10.1002/phar.1594

  2. You have full text access to this OnlineOpen article
    A comparison of linaclotide and lubiprostone dosing regimens on ion transport responses in human colonic mucosa

    Pharmacology Research & Perspectives

    Volume 3, Issue 2, March 2015, Sang Bum Kang, Ronald R. Marchelletta, Harrison Penrose, Michael J. Docherty and Declan F. McCole

    Version of Record online : 13 MAR 2015, DOI: 10.1002/prp2.128

  3. You have full text access to this OnlineOpen article
    A Randomized Study of Lubiprostone for Opioid-Induced Constipation in Patients with Chronic Noncancer Pain

    Pain Medicine

    Volume 15, Issue 11, November 2014, Pages: 1825–1834, Byron Cryer, Seymour Katz, Ricardo Vallejo, Anca Popescu and Ryuji Ueno

    Version of Record online : 9 APR 2014, DOI: 10.1111/pme.12437

  4. Treatment for constipation: New and old pharmacological strategies

    Neurogastroenterology & Motility

    Volume 26, Issue 6, June 2014, Pages: 749–763, B. E. Lacy, Z. H. Hussain and F. Mearin

    Version of Record online : 23 MAY 2014, DOI: 10.1111/nmo.12335

  5. You have free access to this content
    Lubiprostone targets prostanoid EP4 receptors in ovine airways

    British Journal of Pharmacology

    Volume 162, Issue 2, January 2011, Pages: 508–520, AW Cuthbert

    Version of Record online : 14 DEC 2010, DOI: 10.1111/j.1476-5381.2010.01058.x

  6. You have free access to this content
    Lubiprostone, a locally acting chloride channel activator, in adult patients with chronic constipation: a double-blind, placebo-controlled, dose-ranging study to evaluate efficacy and safety

    Alimentary Pharmacology & Therapeutics

    Volume 25, Issue 11, June 2007, Pages: 1351–1361, J. F. JOHANSON and R. UENO

    Version of Record online : 20 MAR 2007, DOI: 10.1111/j.1365-2036.2007.03320.x

  7. Efficacy and safety of oral lubiprostone in constipated patients with or without irritable bowel syndrome: a randomized, placebo-controlled and dose-finding study

    Neurogastroenterology & Motility

    Volume 23, Issue 6, June 2011, Pages: 544–e205, S. Fukudo, M. Hongo, H. Kaneko and R. Ueno

    Version of Record online : 9 FEB 2011, DOI: 10.1111/j.1365-2982.2011.01668.x

  8. You have free access to this content
    Clinical trial: phase 2 study of lubiprostone for irritable bowel syndrome with constipation

    Alimentary Pharmacology & Therapeutics

    Volume 27, Issue 8, April 2008, Pages: 685–696, J. F. JOHANSON, D. A. DROSSMAN, R. PANAS, A. WAHLE and R. UENO

    Version of Record online : 30 JAN 2008, DOI: 10.1111/j.1365-2036.2008.03629.x

  9. Lubiprostone for Opioid-Induced Constipation Does Not Interfere with Opioid Analgesia in Patients with Chronic Noncancer Pain

    Pain Practice

    Volume 17, Issue 3, March 2017, Pages: 312–319, Egilius L. H. Spierings, Randall P. Brewer, Richard L. Rauck, Taryn Losch-Beridon and Shadreck M. Mareya

    Version of Record online : 15 MAR 2016, DOI: 10.1111/papr.12444

  10. You have full text access to this OnlineOpen article
    Effects of baseline abdominal pain and bloating on response to lubiprostone in patients with irritable bowel syndrome with constipation

    Alimentary Pharmacology & Therapeutics

    Volume 44, Issue 10, November 2016, Pages: 1114–1122, L. Chang, W. D. Chey, D. Drossman, T. Losch-Beridon, M. Wang, P. Lichtlen and S. Mareya

    Version of Record online : 27 SEP 2016, DOI: 10.1111/apt.13807

  11. You have free access to this content
    Activation of prostaglandin EP receptors by lubiprostone in rat and human stomach and colon

    British Journal of Pharmacology

    Volume 154, Issue 1, May 2008, Pages: 126–135, A K Bassil, R A Borman, E M Jarvie, R J McArthur-Wilson, R Thangiah, E Z H Sung, K Lee and G J Sanger

    Version of Record online : 29 JAN 2009, DOI: 10.1038/bjp.2008.84

  12. You have free access to this content
    Clinical trial: lubiprostone in patients with constipation-associated irritable bowel syndrome – results of two randomized, placebo-controlled studies

    Alimentary Pharmacology & Therapeutics

    Volume 29, Issue 3, February 2009, Pages: 329–341, D. A. DROSSMAN, W. D. CHEY, J. F. JOHANSON, R. FASS, C. SCOTT, R. PANAS and R. UENO

    Version of Record online : 4 NOV 2008, DOI: 10.1111/j.1365-2036.2008.03881.x

  13. Long-Term Safety and Efficacy of Lubiprostone in Opioid-induced Constipation in Patients with Chronic Noncancer Pain

    Pain Practice

    Volume 16, Issue 8, November 2016, Pages: 985–993, Egilius L.H. Spierings, Richard Rauck, Randall Brewer, Stefano Marcuard and Ricardo Vallejo

    Version of Record online : 29 AUG 2015, DOI: 10.1111/papr.12347

  14. Lubiprostone does not influence visceral pain thresholds in patients with irritable bowel syndrome

    Neurogastroenterology & Motility

    Volume 23, Issue 10, October 2011, Pages: 944–e400, W. E. Whitehead, O. S. Palsson, L. Gangarosa, M. Turner and J. Tucker

    Version of Record online : 14 SEP 2011, DOI: 10.1111/j.1365-2982.2011.01776.x

  15. Pharmacology of the New Treatments for Lower Gastrointestinal Motility Disorders and Irritable Bowel Syndrome

    Clinical Pharmacology & Therapeutics

    Volume 91, Issue 1, January 2012, Pages: 44–59, M Camilleri

    Version of Record online : 9 NOV 2011, DOI: 10.1038/clpt.2011.261

  16. You have free access to this content
    Safety and patient outcomes with lubiprostone for up to 52 weeks in patients with irritable bowel syndrome with constipation

    Alimentary Pharmacology & Therapeutics

    Volume 35, Issue 5, March 2012, Pages: 587–599, W. D. Chey, D. A. Drossman, J. F. Johanson, C. Scott, R. M. Panas and R. Ueno

    Version of Record online : 18 JAN 2012, DOI: 10.1111/j.1365-2036.2011.04983.x

  17. You have free access to this content
    2006 Joint International Society Meeting in Neurogastroenterology and GI Motility

    Neurogastroenterology & Motility

    Volume 18, Issue 8, August 2006, Pages: 663–798,

    Version of Record online : 17 JUL 2006, DOI: 10.1111/j.1365-2982.2006.00826.x

  18. Novel Oral Therapies for Opioid-induced Bowel Dysfunction in Patients with Chronic Noncancer Pain

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 36, Issue 3, March 2016, Pages: 287–299, Renee M. Holder and Diane Rhee

    Version of Record online : 6 MAR 2016, DOI: 10.1002/phar.1711

  19. You have free access to this content
    Chloride transporting capability of Calu-3 epithelia following persistent knockdown of the cystic fibrosis transmembrane conductance regulator, CFTR

    British Journal of Pharmacology

    Volume 150, Issue 8, April 2007, Pages: 1055–1065, L J MacVinish, G Cope, A Ropenga and A W Cuthbert

    Version of Record online : 29 JAN 2009, DOI: 10.1038/sj.bjp.0707175

  20. You have free access to this content
    Abstracts

    Neurogastroenterology & Motility

    Volume 20, Issue s2, November 2008, Pages: 1–144,

    Version of Record online : 1 OCT 2008, DOI: 10.1111/j.1365-2982.2008.01190.x